Recent House passage of the Stop Insider Trading Act in July 2026, which narrowly restricts new individual stock purchases by members and families while permitting existing holdings, has not translated into swift Senate action. The bill arrived in the upper chamber with attached voter identification provisions that have drawn Democratic opposition and created procedural hurdles. Senate versions remain in committee or face uncertain floor time amid the compressed 2026 calendar, including the August recess and November midterms. Bipartisan but stricter proposals requiring full divestiture or blind trusts have stalled without majority support. These dynamics, combined with longstanding Senate reluctance on ethics measures absent broad consensus, underpin trader expectations that no comprehensive congressional stock trading ban will clear both chambers and reach the president before 2027.